Anterior and conventional hepatectomy equally safe, effective for colorectal cancer: JAMA
Germany: Anterior approach is not superior to conventional hepatectomy for the reduction of tumor cell dissemination in patients undergoing resection of colorectal liver metastasis (CRLM), finds a recent study. The findings of the study, published in the journal JAMA Surgery, suggest that there is no significant difference in postoperative outcome or long-term survival in two techniques and also both are safe.
Tumor relapse is a common unresolved issue that occurs after partial hepatectomy for CRLM. During conventional hepatectomy, intraoperative manipulation of the liver might enhance the spread of hematogenous tumor cell. The anterior approach is an alternative approach that may help in reducing intraoperative tumor cell dissemination. Considering this Nuh N. Rahbari, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany, and colleagues determined the safety and efficacy of the anterior approach compared with conventional hepatectomy in patients undergoing resection for CRLM from February 1, 2003, to March 31, 2012, at a tertiary-care hospital.
The study included a total of 80 patients with CRLM who were randomized in the ratio 1:1 to the anterior approach and conventional hepatectomy groups. Blood samples and bone marrow were analyzed for disseminated tumor cells and circulating tumor cells (CTC) using cytokeratin 20 reverse transcriptase–polymerase chain reaction analysis.
The primary end point was intraoperative CTC detection in central blood samples after liver resection. Secondary end points included postoperative morbidity, mortality, and long-term survival.
Key findings of the study include:
- There was no statistically significant difference in intraoperative CTC detection between patients in the conventional hepatectomy (24%) and anterior approach (27%).
- Except for a longer operating time in the anterior approach group (mean [SD], 171 vs 221 minutes), there were no significant differences in intraoperative and postoperative outcomes between both study groups.
- Although detection of CTC was associated with poor overall (median, 46 vs 81 months) and disease-free (median, 40 vs 60 months) survival, there was no significant difference in overall (median, 73 vs 55 months) and disease-free (median, 48 vs 40 months) survival between the conventional hepatectomy and anterior approach groups.
- There was no significant difference in patterns of recurrence between both groups.
"These findings suggest that both techniques offer safe and comparable postoperative and survival outcomes in patients undergoing right-sided hepatectomy for colorectal cancer," concluded the authors.
"Anterior Approach vs Conventional Hepatectomy for Resection of Colorectal Liver Metastasis: A Randomized Clinical Trial," is published in the journal JAMA Surgery,
DOI: https://jamanetwork.com/journals/jamasurgery/fullarticle/2772624
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.